Drug Information

Drug General Information
Drug ID
D0P6TX
Former ID
DNC006105
Drug Name
1-(3-benzyloxy-pyridin-2-yl)-3-phenyl-urea
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527996]
Structure
Download
2D MOL

3D MOL
Formula
C19H17N3O2
Canonical SMILES
C1=CC=C(C=C1)COC2=C(N=CC=C2)NC(=O)NC3=CC=CC=C3
InChI
1S/C19H17N3O2/c23-19(21-16-10-5-2-6-11-16)22-18-17(12-7-13-20-18)24-14-15-8-3-1-4-9-15/h1-13H,14H2,(H2,20,21,22,23)
InChIKey
PFMMAQSZJDBKOE-UHFFFAOYSA-N
PubChem Compound ID
3663276
Target and Pathway
Target(s) Peptidyl-prolyl cis-trans isomerase A Target Info Inhibitor [527996]
Reactome Platelet degranulation
Uncoating of the HIV Virion
Budding and maturation of HIV virion
Integration of provirus
Early Phase of HIV Life Cycle
Minus-strand DNA synthesis
Plus-strand DNA synthesis
Binding and entry of HIV virion
Assembly Of The HIV Virion
APOBEC3G mediated resistance to HIV-1 infection
Basigin interactions
WikiPathways Signaling by the B Cell Receptor (BCR)
Host Interactions of HIV factors
HIV Life Cycle
JAK/STAT
Cell surface interactions at the vascular wall
References
Ref 527996J Med Chem. 2006 Feb 9;49(3):900-10.Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A.
Ref 527996J Med Chem. 2006 Feb 9;49(3):900-10.Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.